X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://synactpharma.com/en/approval-of-amended-study-protocol-for-the-phase-2a-study-in-imn/
https://news.cision.com/synact/r/synact-announces-outcome-of-rights-issue,c3552845
https://www.prnewswire.com/news-releases/synact-pharma-announces-positive-interim-phase-2-data-of-ap1189-in-rheumatoid-arthritis-301168425.html